Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 7,500 shares at $3.58 ($27K) on 2019-08-06, disclosed to the SEC on 2019-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.58 | 5,000 | $18K | 66.9% |
| 2 | $3.54 | 2,500 | $9K | 33.1% |
| Total | $3.57 avg | 7,500 | $27K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |